Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
The current FDA commissioner has been supportive of obesity drug development, but political changes are unpredictable
In December 2025, this breakthrough technology expanded to weight management when the FDA approved the Wegovy pill the first oral GLP-1 medication specifically for obesity and weight loss
Do not freeze the vials or expose them to excessive heat
Semaglutide is a fairly new drug treatment for weight loss in non-diabetics
Focus on sustainable habits, stay connected with your care team, and know that managing weight is a long-term process with many possible strategies along the way
Long storage times past the expiration date can lead to changes in the stability of the medication, which might cause floating particles or cloudiness
![Cardiology Diabetes articles page [4]](https://assets.medpagetoday.net/media/images/116xxx/116170_m.jpg)
